Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Gentamicin-induced stop codon readthrough shows benefit in a retinitis pigmentosa rat model

May 9, 2007

Topically applied TG-101095 shows promise in a murine laser-induced CNV model

May 9, 2007

The mTOR inhibitor QLT-0447 potently suppresses CNV in vivo

May 9, 2007

Ista withdraws European application for Vitragan

May 9, 2007

Sphingozumab effective in animal models of laser-induced CNV

May 9, 2007

Immunotherapy with MHC II-expressing tumor cells may be useful in uveal melanoma

May 8, 2007

AL-39324 reduces ocular angiogenesis in different animal models in vivo

May 8, 2007

Ista receives non approvable letter for T-Pred

May 7, 2007

Lux receives Canadian clearance for phase II/III trials of LX-211 in uveitis

May 7, 2007

In vivo antiangiogenic activity of Immusol's new compound, IMS-2186

May 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...